Immunome (IMNM) Change in Account Payables (2019 - 2026)
Immunome's (IMNM) quarterly Change in Account Payables came in at $1.4 million in Q1 2026, up 137.3% YoY from $598828.7 in Q1 2025, and up 162.41% on a QoQ basis from -$2.3 million in Q4 2025.
Immunome (IMNM) Change in Account Payables (2019 - 2026) Analysis & Trends
Immunome (IMNM) has 8 years of Change in Account Payables data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Change in Account Payables rose 137.3% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.9 million (down 218.46% YoY) and the FY2025 annual result came in at -$9.2 million, down 196.2% from the prior year.
- Change in Account Payables improved to $1.4 million in Q1 2026, from -$2.3 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $9.3 million in Q4 2024 to a low of -$4.9 million in Q2 2025.
- A 5-year average of $29294.1 and a median of -$32000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables soared 1465.24% — and 2025, when it slumped 15362.5%.
- Tracing IMNM's Change in Account Payables over 5 years: stood at -$739000.0 in 2022, then grew by 8.12% to -$679000.0 in 2023, then soared by 1465.24% to $9.3 million in 2024, then tumbled by 124.56% to -$2.3 million in 2025, then soared by 162.41% to $1.4 million in 2026.
- The last three Change in Account Payables figures came in at $1.4 million (Q1 2026), -$2.3 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19 Mn |
| Jun 30, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | -4.95 Mn |
| Jun 30, 2025 | -4.95 Mn |
| Mar 31, 2025 | -3.81 Mn |
| Mar 31, 2025 | -3.81 Mn |
| Dec 31, 2024 | 9.27 Mn |
| Dec 31, 2024 | 9.27 Mn |
| Sep 30, 2024 | -2.11 Mn |
| Sep 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -32,000.00 |
| Jun 30, 2024 | -32,000.00 |
| Mar 31, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.40 Mn |